The 2nd Conference on Pharmacovigilance and Drug Safety (CPDS 2016)
will be held from June 1 to 3, 2016 in Nanjing, China. This Conference will cover issues on Pharmacovigilance and Drug Safety. It dedicates to creating a stage for exchanging the latest research results and sharing the advanced research methods.
CPDS 2016 will be co-located with the following conferences:
The 2nd Conference on Ethnomedicine and Traditional Medicine (CETM 2016)
The 2nd Int'l Conference on Pharmacology and Toxicology (ICPT 2016)
The 2nd Int'l Conference on Reproductive Medicine (ICRM 2016)
The 2nd Conference on Plastic and Aesthetic Medicine (CPAM 2016)
The 2nd Conference on Advances in Medical Education (CAME 2016)
CPDS 2016 is devoted to the advancement of Pharmacovigilance and Drug Safety. Pharmacovigilance (PV or PhV), also known as Drug Safety, is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. Pharmacovigilance heavily focuses on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy. Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest (even without adverse event itself), because they may result in an ADR. The scope of CPDS 2016 covers both theoretical and practical areas of Pharmacovigilance and Drug Safety, and the detailed areas of interest for this Conference are listed in the section of "Call for Papers".
CPDS 2016 will be a valuable and important platform for inspiring international and interdisciplinary exchange at the forefront of Pharmacovigilance and Drug Safety. The Conference will bring together academicians, medical scientists/practitioners, biologists and pharmacists/chemists from all over the world, and we hope that you will take this opportunity to join us for academic exchange and visit the city of Nanjing.
We look forward to seeing you in Nanjing.
Presentation and Recommendation
All the accepted papers will be published by "Journal of Biosciences and Medicines" (ISSN:2327-5081), a peer-reviewed open access journal that can ensure the widest dissemination of your published work. For more information, please visit: http://www.scirp.org/journal/jbm/
You're welcome to submit abstracts for presentation. The abstracts are only used for an oral presentation and will not be published in the conference journal.